Tenax Therapeutics (TENX) Accumulated Depreciation (2013 - 2021)
Tenax Therapeutics recorded quarterly Accumulated Depreciation of $60843.0 in Q2 2021, up 1.48% quarter-over-quarter from $59953.0 in Q1 2021, and little changed year-over-year from $60905.0 in Q2 2020.
Tenax Therapeutics' Accumulated Depreciation history runs 8 years deep, the most recent figure standing at $60843.0 for Q2 2021.
- In Q2 2021, Accumulated Depreciation changed 0.1% year-over-year to $60843.0; the TTM figure through Jun 2021 stood at $60843.0 (changed 0.1% YoY), while the FY2020 annual figure was $60368.0, down 70.45% from the prior year.
- Accumulated Depreciation came in at $60843.0 for Q2 2021 at Tenax Therapeutics, up from $59953.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $573121.0 in Q4 2018 to a low of $59389.0 in Q3 2020.
- A 4-year average of $161658.2 and a median of $74785.0 in 2020 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation slumped 70.74% in 2020 and slipped 0.1% in 2021, its largest moves.
- Tenax Therapeutics' Accumulated Depreciation stood at $573121.0 in 2018, then slumped by 64.35% to $204302.0 in 2019, then tumbled by 70.45% to $60368.0 in 2020, then climbed by 0.79% to $60843.0 in 2021.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $60843.0, $59953.0, and $60368.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 60,843.00 |
| Mar 31, 2021 | 59,953.00 |
| Dec 31, 2020 | 60,368.00 |
| Sep 30, 2020 | 59,389.00 |
| Jun 30, 2020 | 60,905.00 |
| Mar 31, 2020 | 74,785.00 |
| Dec 31, 2019 | 204,302.00 |
| Sep 30, 2019 | 202,993.00 |
| Jun 30, 2019 | 201,684.00 |
| Mar 31, 2019 | 219,897.00 |
| Dec 31, 2018 | 573,121.00 |
| Mar 31, 2016 | 753,241.00 |
| Dec 31, 2015 | 748,604.00 |
| Apr 30, 2015 | 717,379.00 |
| Jan 31, 2015 | -869,111.00 |
| Oct 31, 2014 | -874,558.00 |
| Jul 31, 2014 | -853,610.00 |
| Apr 30, 2014 | -831,830.00 |
| Jan 31, 2014 | -893,194.00 |
| Oct 31, 2013 | -872,543.00 |
| Jul 31, 2013 | -849,986.00 |
| Apr 30, 2013 | -828,752.00 |